• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤中的肿瘤相关巨噬细胞:从机制到治疗。

Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy.

机构信息

Department of Biotechnology Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.

Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.

出版信息

Int J Mol Sci. 2020 Jul 23;21(15):5207. doi: 10.3390/ijms21155207.

DOI:10.3390/ijms21155207
PMID:32717819
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7432207/
Abstract

Osteosarcomas (OSs) are bone tumors most commonly found in pediatric and adolescent patients characterized by high risk of metastatic progression and recurrence after therapy. Effective therapeutic management of this disease still remains elusive as evidenced by poor patient survival rates. To achieve a more effective therapeutic management regimen, and hence patient survival, there is a need to identify more focused targeted therapies for OSs treatment in the clinical setting. The role of the OS tumor stroma microenvironment plays a significant part in the development and dissemination of this disease. Important components, and hence potential targets for treatment, are the tumor-infiltrating macrophages that are known to orchestrate many aspects of OS stromal signaling and disease progression. In particular, increased infiltration of M2-like tumor-associated macrophages (TAMs) has been associated with OS metastasis and poor patient prognosis despite currently used aggressive therapies regimens. This review aims to provide a summary update of current macrophage-centered knowledge and to discuss the possible roles that macrophages play in the process of OS metastasis development focusing on the potential influence of stromal cross-talk signaling between TAMs, cancer-stem cells and additional OSs tumoral microenvironment factors.

摘要

骨肉瘤(OSs)是最常见于儿科和青少年患者的骨肿瘤,其特征是治疗后转移进展和复发的风险高。尽管患者的生存率仍然很差,但这种疾病的有效治疗管理仍然难以实现。为了实现更有效的治疗管理方案,从而提高患者的生存率,需要在临床环境中为 OS 治疗确定更有针对性的靶向治疗方法。OS 肿瘤基质微环境的作用在疾病的发展和传播中起着重要作用。重要的组成部分,也是治疗的潜在靶点,是浸润肿瘤的巨噬细胞,已知其可以协调 OS 基质信号和疾病进展的许多方面。特别是,尽管目前使用了积极的治疗方案,但 M2 样肿瘤相关巨噬细胞(TAMs)的浸润增加与 OS 转移和患者预后不良有关。本综述旨在提供当前以巨噬细胞为中心的知识的最新总结,并讨论巨噬细胞在 OS 转移发展过程中可能发挥的作用,重点关注 TAMs、癌症干细胞和其他 OS 肿瘤微环境因素之间基质交叉对话信号的潜在影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/7432207/79435267a27a/ijms-21-05207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/7432207/1b4c13dcf9fa/ijms-21-05207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/7432207/79435267a27a/ijms-21-05207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/7432207/1b4c13dcf9fa/ijms-21-05207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/7432207/79435267a27a/ijms-21-05207-g002.jpg

相似文献

1
Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy.骨肉瘤中的肿瘤相关巨噬细胞:从机制到治疗。
Int J Mol Sci. 2020 Jul 23;21(15):5207. doi: 10.3390/ijms21155207.
2
Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma.分析 M2 巨噬细胞衍生的 PDE4C 对骨肉瘤预后、转移和免疫治疗获益的影响。
J Cell Mol Med. 2024 May;28(10):e18395. doi: 10.1111/jcmm.18395.
3
The role of tumor-associated macrophages in osteosarcoma progression - therapeutic implications.肿瘤相关巨噬细胞在骨肉瘤进展中的作用——治疗意义。
Cell Oncol (Dordr). 2021 Jun;44(3):525-539. doi: 10.1007/s13402-021-00598-w. Epub 2021 Mar 31.
4
Tumor-associated macrophages in osteosarcoma.骨肉瘤中的肿瘤相关巨噬细胞。
J Zhejiang Univ Sci B. 2021 Nov 15;22(11):885-892. doi: 10.1631/jzus.B2100029.
5
The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response.骨肉瘤的免疫景观:对预后和治疗反应的影响。
Cells. 2021 Jul 2;10(7):1668. doi: 10.3390/cells10071668.
6
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.CSF1/CSF1R 信号抑制剂培西达替尼(PLX3397)重塑肉瘤微环境中的肿瘤相关巨噬细胞并刺激 T 细胞浸润。
Mol Cancer Ther. 2021 Aug;20(8):1388-1399. doi: 10.1158/1535-7163.MCT-20-0591. Epub 2021 Jun 4.
7
Identification and Functional Analysis of EPOR Tumor-Associated Macrophages in Human Osteosarcoma Lung Metastasis.人骨肉瘤肺转移中 EPOR 肿瘤相关巨噬细胞的鉴定和功能分析。
J Immunol Res. 2020 Aug 18;2020:9374240. doi: 10.1155/2020/9374240. eCollection 2020.
8
Bone Microenvironment and Osteosarcoma Metastasis.骨微环境与骨肉瘤转移。
Int J Mol Sci. 2020 Sep 23;21(19):6985. doi: 10.3390/ijms21196985.
9
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes.转移性骨肉瘤中免疫排斥的途径与患者预后不良相关。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-001772.
10
Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.巨噬细胞极化失调与骨肉瘤的转移过程相关。
Oncotarget. 2016 Nov 29;7(48):78343-78354. doi: 10.18632/oncotarget.13055.

引用本文的文献

1
Multiplex Imaging Mass Cytometry Reveals Prognostic Immunosuppressive Subpopulations and Macrophage-Driven Metastasis in Osteosarcoma.多重成像质谱流式细胞术揭示骨肉瘤的预后免疫抑制亚群和巨噬细胞驱动的转移
Cancers (Basel). 2025 Aug 26;17(17):2780. doi: 10.3390/cancers17172780.
2
High Levels of Systemic Inflammatory Markers Associated with Metastasis Incidence in Osteosarcoma.骨肉瘤中与转移发生率相关的高水平全身炎症标志物
Rev Bras Ortop (Sao Paulo). 2025 Sep 8;60(3):s00451810032. doi: 10.1055/s-0045-1810032. eCollection 2025 Jun.
3
[High Levels of Systemic Inflammatory Markers Associated with Metastasis Incidence in Osteosarcoma].

本文引用的文献

1
Retracted Article: Macrophage-derived exosomes mediate osteosarcoma cell behavior by activating AKT signaling.撤稿文章:巨噬细胞来源的外泌体通过激活AKT信号传导介导骨肉瘤细胞行为。
RSC Adv. 2020 Jan 30;10(9):5032-5039. doi: 10.1039/c9ra07332a. eCollection 2020 Jan 29.
2
Extracellular-Regulated Protein Kinase 5-Mediated Control of p21 Expression Promotes Macrophage Proliferation Associated with Tumor Growth and Metastasis.细胞外调节蛋白激酶 5 介导的 p21 表达调控促进与肿瘤生长和转移相关的巨噬细胞增殖。
Cancer Res. 2020 Aug 15;80(16):3319-3330. doi: 10.1158/0008-5472.CAN-19-2416. Epub 2020 Jun 19.
3
Human chimeric antigen receptor macrophages for cancer immunotherapy.
[骨肉瘤中与转移发生率相关的高水平全身炎症标志物]
Rev Bras Ortop (Sao Paulo). 2025 Sep 8;60(3):s00451810033. doi: 10.1055/s-0045-1810033. eCollection 2025 Jun.
4
Induction of the STING-dependent DNA damage pathway by cucurbitacin B enhances immunotherapy efficacy in osteosarcoma.葫芦素B诱导STING依赖的DNA损伤途径增强骨肉瘤免疫治疗疗效
Iran J Basic Med Sci. 2025;28(10):1319-1327. doi: 10.22038/ijbms.2025.86376.18663.
5
Deubiquitinase Genes as Prognostic Biomarkers in Osteosarcoma: Insights From Single-Cell Sequencing and Machine Learning-Based Prognostic Modeling.去泛素化酶基因作为骨肉瘤的预后生物标志物:来自单细胞测序和基于机器学习的预后建模的见解
Int J Genomics. 2025 Aug 17;2025:7932638. doi: 10.1155/ijog/7932638. eCollection 2025.
6
Immune-Modulating Dual-Targeted Nanomaterials for Low-Temperature Photothermal-Photodynamic-Chemodynamic Therapy of Osteosarcoma Targeting Tumor and Endothelial Cells.用于骨肉瘤低温光热-光动力-化学动力疗法的免疫调节双靶点纳米材料,靶向肿瘤细胞和内皮细胞
ACS Nano. 2025 Sep 2;19(34):30786-30809. doi: 10.1021/acsnano.5c00223. Epub 2025 Aug 20.
7
NF-κB signaling pathway in osteosarcoma: from signaling networks to targeted therapy.骨肉瘤中的核因子κB信号通路:从信号网络到靶向治疗
Front Oncol. 2025 Jul 25;15:1565760. doi: 10.3389/fonc.2025.1565760. eCollection 2025.
8
Graviola Induces Apoptosis in Two Osteosarcoma Cell Lines and Downregulates the Cytokines IL-6 and TGFβ1 Which Are Implicated in Tumour Growth and Metastasis.刺果番荔枝诱导两种骨肉瘤细胞系凋亡,并下调与肿瘤生长和转移相关的细胞因子白细胞介素-6和转化生长因子β1。
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251360338. doi: 10.1177/15347354251360338. Epub 2025 Jul 30.
9
SPON2 facilitates osteosarcoma development by inducing M2 macrophage polarization through activation of the NF-κB/VEGF signaling axis.SPON2通过激活NF-κB/VEGF信号轴诱导M2巨噬细胞极化,从而促进骨肉瘤的发展。
Cell Death Discov. 2025 Jul 29;11(1):352. doi: 10.1038/s41420-025-02626-2.
10
Advances in research on SATB2 and its role in tumor development.SATB2的研究进展及其在肿瘤发生中的作用
Cell Biosci. 2025 Jul 28;15(1):111. doi: 10.1186/s13578-025-01439-1.
用于癌症免疫疗法的人嵌合抗原受体巨噬细胞。
Nat Biotechnol. 2020 Aug;38(8):947-953. doi: 10.1038/s41587-020-0462-y. Epub 2020 Mar 23.
4
Prognostic Significance of β-Catenin Expression in Osteosarcoma: A Meta-Analysis.β-连环蛋白在骨肉瘤中的表达的预后意义:一项Meta分析
Front Oncol. 2020 Apr 9;10:402. doi: 10.3389/fonc.2020.00402. eCollection 2020.
5
The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.成骨肉瘤微环境:一个复杂但可靶向的生态系统。
Cells. 2020 Apr 15;9(4):976. doi: 10.3390/cells9040976.
6
Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions.转移性骨肉瘤细胞的外泌体通讯可将肺泡巨噬细胞调节为促进肿瘤的M2表型,并抑制其杀瘤功能。
Oncoimmunology. 2020 Apr 12;9(1):1747677. doi: 10.1080/2162402X.2020.1747677. eCollection 2020.
7
Macrophages reduce the sensitivity of osteosarcoma to neoadjuvant chemotherapy drugs by secreting Interleukin-1 beta.巨噬细胞通过分泌白细胞介素-1β降低骨肉瘤对新辅助化疗药物的敏感性。
Cancer Lett. 2020 Jun 28;480:4-14. doi: 10.1016/j.canlet.2020.03.019. Epub 2020 Mar 24.
8
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.骨肉瘤患者中癌症易感性基因种系致病性变异的频率。
JAMA Oncol. 2020 May 1;6(5):724-734. doi: 10.1001/jamaoncol.2020.0197.
9
Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells.米伐木肽与TAM样巨噬细胞:对骨肉瘤细胞增殖、迁移及分化的影响
Oncotarget. 2020 Feb 18;11(7):687-698. doi: 10.18632/oncotarget.27479.
10
The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis.一线化疗药物(高剂量甲氨蝶呤、阿霉素、顺铂和异环磷酰胺)治疗骨肉瘤的疗效和安全性比较:一项网络荟萃分析。
J Orthop Surg Res. 2020 Feb 13;15(1):51. doi: 10.1186/s13018-020-1576-0.